AbbVie Inc.
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 51.3T 54.3B 58.1B 56.2B
Cost of revenue 15.4T 20.4B 17.4B 17.4B
Gross profit 35.9T 33.9B 40.6B 38.8B
Operating expense
Research & development 11.6T 8.5B 7.2B 8.0B
Selling general and admin 13.4T 12.9B 15.3B 12.3B
Other operating expenses -6.4B -179M 56M 432M
Operating income 10.8T 12.8B 18.1B 17.9B
Non operating interest income
Income 590.0B 540M 186M 39M
Expense 2.6T 2.2B 2.2B 2.4B
Other income expense -5.5T -4.8B -2.6B -2.6B
Pretax income 3.4T 6.3B 13.5B 13.0B
Tax provision -519.0B 1.4B 1.6B 1.4B
Net income 3.9T 4.9B 11.8B 11.5B
Basic EPS 2.4 2.7 6.7 6.5
Diluted EPS 2.4 2.7 6.6 6.5
Basic average shares 1.6T 1.9M 1.9M 1.9M
Diluted average shares 1.6T 1.9M 1.9M 1.9M
EBITDA 16.1T 17.3B 24.3B 24.0B
Net income from continuing op. 3.9T 4.9B 11.8B 11.5B
Minority interests -8M -10M -9M -7M
Preferred stock dividends 36.4B 43M 54M 74M
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 12 hours 27 minutes

21:02
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Main market
09:30 - 16:00
All times are displayed in the America/Santiago timezone (-03, UTC-03:00).